T2 Biosystems, Inc.

NASDAQ:TTOO

0.36 (USD) • At close December 23, 2024
Bedrijfsnaam T2 Biosystems, Inc.
Symbool TTOO
Munteenheid USD
Prijs 0.359
Beurswaarde 7,552,333
Dividendpercentage 0%
52-weken bereik 0.31 - 8.38
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. John J. Sperzel III, B.Sc.
Website https://www.t2biosystems.com

An error occurred while fetching data.

Over T2 Biosystems, Inc.

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company

Vergelijkbare Aandelen

ARCA biopharma, Inc. logo

ARCA biopharma, Inc.

ABIO

28.8 USD

vTv Therapeutics Inc. logo

vTv Therapeutics Inc.

VTVT

13.87 USD

Immix Biopharma, Inc. logo

Immix Biopharma, Inc.

IMMX

2.18 USD

Avalo Therapeutics, Inc. logo

Avalo Therapeutics, Inc.

AVTX

9.09 USD

Acer Therapeutics Inc. logo

Acer Therapeutics Inc.

ACER

0.66 USD

FSD Pharma Inc. logo

FSD Pharma Inc.

HUGE

0.09 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)